ArticleRSC advances2023
Fabrication and characterization of mesoporous yolk-shell nanocomposites as an effective reusable heterogeneous base catalyst for the synthesis of
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesoporous yolk-shell nanocomposites (MYSNs) were loaded with a mobile CaMg core inside the silica shell. CaMg@MYS nanocomposites have been effectively prepared inside the inner cavity of a novel structure that consists of hollow mesoporous silica spheres. Tetraethyl orthosilicate (TEOS) and an amount of cetyltrimethylammonium bromide (CTAB) are coated on the carbon spheres used as a hard template in the multi-step synthetic procedure. In this method, the target products were obtained in high to excellent yields between 87-96% and quick response times between 10-20 minutes under mild conditions. The CaMg@MYS catalyst shows promise as an efficient and reusable catalyst in multicomponent processes. The CaMg@MYS multi-yolk spheres compared to metal oxide nanostructures indicated both high catalytic performance and a significant factor as a novelty. To identify each product, FT-IR,
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.